Two Sigma Advisers Portfolio holdings
AUM
$48.8B
1-Year Return
29.82%
This Quarter Return
-2.68%
1 Year Return
+29.82%
3 Year Return
+107.12%
5 Year Return
+201.81%
10 Year Return
+492.86%
AUM
$39B
AUM Growth
-$220M
(-0.56%)
Cap. Flow
+$1.45B
Cap. Flow
% of AUM
3.7%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
2,663
New
306
Increased
844
Reduced
1,189
Closed
301
Top Buys
| 1 |
Microsoft
MSFT
|
+$566M |
| 2 |
Tesla
TSLA
|
+$479M |
| 3 |
Amazon
AMZN
|
+$449M |
| 4 |
Advanced Micro Devices
AMD
|
+$388M |
| 5 |
Qualcomm
QCOM
|
+$343M |
Top Sells
| 1 |
Charles Schwab
SCHW
|
+$357M |
| 2 |
Union Pacific
UNP
|
+$340M |
| 3 |
Walmart
WMT
|
+$239M |
| 4 |
Citigroup
C
|
+$180M |
| 5 |
ConocoPhillips
COP
|
+$178M |
Sector Composition
| 1 | Technology | 24.96% |
| 2 | Healthcare | 15.25% |
| 3 | Consumer Discretionary | 13.96% |
| 4 | Industrials | 10.41% |
| 5 | Financials | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADAP
2276
Adaptimmune Therapeutics
ADAP
$11.3M
| $50.3K | ﹤0.01% |
64,437
-32,500
| -34% | -$25.4K |
|
|
VCSA
2277
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $50.3K | ﹤0.01% |
5,450
+1,235
| +29% | +$11.4K |
|
|
HEPS
2278
D-Market Electronic Services & Trading
HEPS
$916M
| $50.1K | ﹤0.01% |
37,700
-77,600
| -67% | -$103K |
|
|
SUPV
2279
Grupo Supervielle
SUPV
$533M
| $50K | ﹤0.01% |
22,500
-26,100
| -54% | -$57.9K |
|
2280
Karyopharm Therapeutics
KPTI
$54.2M
| $47.2K | ﹤0.01% |
2,347
-15,000
| -86% | -$301K |
|
2281
Protara Therapeutics
TARA
$118M
| $46.5K | ﹤0.01% |
27,818
-3,500
| -11% | -$5.85K |
|
2282
Lineage Cell Therapeutics
LCTX
$283M
| $46.1K | ﹤0.01% |
39,100
-10,499
| -21% | -$12.4K |
|
2283
Aquestive Therapeutics
AQST
$606M
| $46.1K | ﹤0.01% |
30,100
+1,700
| +6% | +$2.6K |
|
2284
Dominari Holdings
DOMH
$94.7M
| $45.7K | ﹤0.01% |
19,700
-900
| -4% | -$2.09K |
|
2285
Heron Therapeutics
HRTX
$199M
| $44.8K | ﹤0.01% |
43,500
-18,000
| -29% | -$18.5K |
|
|
CIO
2286
City Office REIT
CIO
$280M
| $44.6K | ﹤0.01% |
+10,500
| New | +$44.6K |
|
2287
Cumberland Pharmaceuticals
CPIX
$49.5M
| $44.6K | ﹤0.01% |
23,600
| – | – |
|
2288
BioRestorative Therapies
BRTX
$12.8M
| $44K | ﹤0.01% |
24,600
-1,700
| -6% | -$3.04K |
|
2289
Gold Resource Corp
GORO
$116M
| $43.3K | ﹤0.01% |
101,100
+38,900
| +63% | +$16.6K |
|
|
RENT
2290
Rent the Runway
RENT
$24.8M
| $42.3K | ﹤0.01% |
3,110
-180
| -5% | -$2.45K |
|
2291
Advantage Solutions
ADV
$580M
| $40.9K | ﹤0.01% |
+14,400
| New | +$40.9K |
|
2292
GSI Technology
GSIT
$85.2M
| $39.6K | ﹤0.01% |
+14,600
| New | +$39.6K |
|
2293
Acacia Research
ACTG
$326M
| $39.4K | ﹤0.01% |
10,800
-21,700
| -67% | -$79.2K |
|
2294
SuRo Capital
SSSS
$207M
| $39.3K | ﹤0.01% |
10,848
-55,888
| -84% | -$202K |
|
2295
Blend Labs
BLND
$1.13B
| $38.9K | ﹤0.01% |
28,400
+1,700
| +6% | +$2.33K |
|
2296
Applied Therapeutics
APLT
$63.4M
| $38.8K | ﹤0.01% |
15,600
-91,071
| -85% | -$227K |
|
2297
Lexicon Pharmaceuticals
LXRX
$392M
| $38K | ﹤0.01% |
+34,844
| New | +$38K |
|
2298
ESS Tech
GWH
$19.2M
| $35.7K | ﹤0.01% |
1,267
-486
| -28% | -$13.7K |
|
2299
Barnes & Noble Education
BNED
$294M
| $35.4K | ﹤0.01% |
325
-66
| -17% | -$7.19K |
|
|
LILM
2300
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $34.6K | ﹤0.01% |
48,500
+12,300
| +34% | +$8.77K |
|